Add to MyPages

This page will be saved to Cincinnati Children's MyPages, a collection of your favorite places. You can view, organize, or delete your favorites at any time.

 (optional)

E-mail this page

(All fields required)


Please enter a valid e-mail.

Please enter your name.

Please enter a valid e-mail.


Share this on:

James Lab

  • James Lab Research

    My lab reflects both my interests as a scientist and as a pediatric cardiologist. I investigate the pathology behind abnormal heart function, and I am interested in uncovering the mechanisms that help the myocardium adapt to compensate for these abnormalities. One particular subject I study is the misfolded protein response, a mechanism by which the body targets abnormal cellular proteins for removal. In collaboration with Jeffrey Robbins, PhD, and other members of his laboratory, I am exploring the consequences of preamyloid oligomer accumulation (a manifestation of the misfolded protein response) in transgenic mouse models and human myocardium. In this venue, I am actively involved in the training of students and pediatric cardiology fellows.

    My second broad area of interest is echocardiography in research animals. As director of the Mouse Echocardiography Core, I work with research sonographers to obtain detailed anatomic and functional data for a variety of species. We use a Vevo 770 ultrasound system equipped with high-frequency transducers, a tool optimized for small animal imaging. With this system we are able to acquire highly detailed two-dimensional images, as well as M-mode and Doppler images, of the heart and surrounding vascular structures. This imaging ability provides a core service to a number of investigators at Cincinnati Children’s.

  • Lab Publications

    Show All

    2010

    Hinton R, Adelman-Brown J, Witt S, Krishnamurthy V, Gruber M, Osinska H, Sakthivel B, James J, Narmoneva D, Mecham R, Benson D. Elastin haploinsufficiency results in progressive aortic valve malformation and latent valve disease in a mouse model. Circ Res. 107(4):549-57. 2010.

    James J, Hor K, Moga M, Martin L, Robbins J. Effects of myosin heavy chain manipulation in experimental heart failure. J Mol Cell Cardiol. 48(5):999-1006. May, 2010.

    2009

    Suzuki T, Palmer B, James J, Wang Y, Chen V, VanBuren P, Maughan D, Robbins J, LeWinter M. Effects of cardiac myosin isoform variation on myofilament function and crossbridge kinetics in transgenic rabbitsCirc Heart Fail. 2:334-341. 2009.

    2008

    Pattison J, Waggoner J, James J, Martin L, Gulick J, Osinska H, Klevitsky R, Kranias E, Robbins J. Phospholamban overexpression in transgenic rabbits. Transgenic Research. 17:157-170. 2008.

    Other Significant Publications

    Kruger M, Zittrich S, Redwood C, Blaudeck N, James J, Robbins J, Pfitzer G, Stehle R. Effects of the mutation R145G in humancardiac troponin I on the kinetics of the contraction-relaxation cycle inisolated cardiac myofibrils. J. Physiol. 564:347-357.2005.

    James J, Martin L, Krenz M, Quatman C, Jones F, Klevitsky R, Gulick J, Robbins J. Forced expression of alpha-myosin heavy chain in the rabbit ventricle results in cardioprotection under cardiomyopathic conditions. Circulation. 111:2339-2346. 2005.

    Sanbe A, James J, Tuzcu V, Martin L, Gulick J, Osinska H, Sakthivel S, Ginsburg K, Bers D, Ziman B, Lakatta E, Robbins J. Transgenic rabbit model for human troponin I-based hypertrophic cardiomyopathy. Circulation. 111:2330-38. 2005.


  • Lab Presentations

    Show All

    2010

    James J, Osinska H, Malloy C, Margulies K, Robbins J. Accumulation of pre-amyloid oligomer in failing left ventricular myocardium. Keystone Symposium: Cardiovascular Development and Repair, March, 2010; Keystone, CO.

    Kinnett K, Ittenbach R, James J, Cripe L. Prevalence of sinus tachycardia in Duchenne muscular dystrophy. Children’s Hospital of Philadelphia 13th Annual Update of Pediatric Cardiovascular Disease, February, 2010; Lake Buena Vista, FL.

     

    2008

    James J, Moga MA, Robbins J. Effect of Myosin Heavy Chain Composition on Global Cardiac Function in Pressure Overload Hypertrophy. International Society for Heart Research, June, 2008; Cincinnati, OH.

    Cripe L, James J, Spicer R, Kinnett K, Markham L. Continuous intravenous milrinone infusion as therapy for end-stage heart failure in patients with Duchenne muscular dystrophy. Scientific Basis of Heart Failure in Children, May, 2008; Estes Park, CO.

    James J, Markham L, Kinnett K, Benson D, Spicer R,Cripe L. Prevalence of ECG abnormalities in very young Duchenne muscular dystrophy patients. Scientific Basis of Heart Failure in Children, May 2008; Estes Park, CO.

    Other Significant Presentations

    Suzuki T, James J, Wang Y, Palmer B, Van Buren P, Maughan D, Robbins J, LeWinter M. Role of Cardiac Myosin Heavy Chain Isoform Variation in Cross-bridge Kinetics: Results from Transgenic Rabbits. Circulation. 116:II-606. 2007.